CRO News
-
New hope in a ground-breaking clinical trial
CRO | News | 0 Comment | 19 May, 2017
Researchers at the University of Southampton and the University of Leicester are trialing a drug that could boost the body's immune system to fight off mesothelioma, which can be caused by ...Read more
-
A clinical trial of Type-2 Diabetes drug saves life of Bristol man
CRO | News | 0 Comment | 17 May, 2017
When blood tests during the trial revealed some worrying signs, Mel Reynolds took part in the long-term research into drug liraglutide which was used for treating Type 2 diabetes. “A...Read more
-
A clinical study agreement between Regeneron and Inovio
CRO | News | 0 Comment | 08 May, 2017
Regeneron Pharmaceuticals, Inc. and Inovio Pharmaceuticals, Inc. announced a clinical study agreement for a Phase 1b/2a immuno-oncology trial. The study will be conducted by Inovio in patie...Read more
-
NCBS-TIFR aims to garner funds to bolster lifesciences research
CRO | News | 0 Comment | 27 Apr, 2017
NCBS-TIFR which houses the Bangalore Life Science Cluster for advancing modern biological research, has created an Endowment Fund. The Centre intends to garner Rs. 25 crore for this endowme...Read more
-
Gujarat FDCA to launch first mobile drug testing lab in India
CRO | News | 0 Comment | 27 Apr, 2017
The Gujarat Food and Drug Control Administration (FDCA) is all set to launch India's mobile testing lab equipped with high-tech devices in the state by the end of June.One of the best featu...Read more
-
Ecron Acunova completes integration of Syneed Medidata
CRO | News | By BioSpectrum Bureau | 0 Comment | 25 Oct, 2016
Syneed Medidata GmbH, with a strong focus on Non-Interventional Studies (NIS), Data Management and Statistics/SAS-Programming has successfully integrated into the full service CRO Ecron Acu...Read more
-
QuintilesIMS named CRO of the year by F&S
CRO | News | By BioSpectrum Bureau | 0 Comment | 19 Oct, 2016
QuintilesIMS was named Asia Pacific Contract Research Organization (CRO) Company of the Year by Frost & Sullivan, a leading business research and consulting firm. The evaluation used in...Read more
-
PAREXEL launches tracking service for medicinal products
CRO | News | By BioSpectrum Bureau | 0 Comment | 07 Oct, 2016
PAREXEL International Corporation has announced the launch of its Active Tracking service. The service follows Good Distribution Practice (GDP) requirements by providing biopharmaceutical c...Read more
-
CRO | News | By BioSpectrum Bureau | 0 Comment | 05 Oct, 2016
Quintiles IMS Holdings, Inc. announced that it has successfully completed its merger of equals transaction between IMS Health Holdings, Inc. (and Quintiles Transnational Holdings Inc. The m...Read more
-
CRO | News | By BioSpectrum Bureau | 0 Comment | 27 Sep, 2016
PAREXEL International Corporation announced that the Company has entered into a definitive agreement to acquire ExecuPharm, Inc. ("ExecuPharm"), a leading, global functional service provide...Read more
-
Indian govt relaxes clinical trial norms
CRO | News | By BioSpectrum Bureau | 0 Comment | 09 Aug, 2016
In a bid to woo global researchers and improve the clinical trial landscape in the country, the Indian government has decided to relax rules and ease clinical trial procedures in India. The...Read more
-
Vyome Biosciences Closes $14 Million Series C Financing
CRO | News | By BioSpectrum Bureau | 0 Comment | 23 Aug, 2016
Vyome Biosciences, a clinical-stage specialty biopharmaceutical company developing novel medicines for treating skin diseases caused by resistant microbes announced today that it has closed...Read more
-
Ms Annie Hai-yuan Lo joins Quintiles' Board of Directors
CRO | News | By BioSpectrum Bureau | 0 Comment | 03 Oct, 2015
Quintiles Transnational Holdings has announced that Ms Annie Hai-yuan Lo, has been appointed to its Board of Directors, effective immediately. Ms Lo will also serve as a member of the Audit...Read more
-
Mr Bhartia resigns as Jubilant's MD
CRO | News | By BioSpectrum Bureau | 0 Comment | 31 Mar, 2015
Jubilant Life Sciences informed BSE that consequent to appointment of Mr Shyam S Bhartia as chairman and managing director of Jubilant Pharma, Singapore, a wholly-owned subsidiary of Jubila...Read more
-
Syngene likely to go public this July
CRO | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2015
"The DRHP (Draft Red Herring Prospectus) is likely to be filed today," a Syngene spokesperson told Business Standard. Incorporated in 1993, Syngene offers integrated discovery and developme...Read more
-
'We need right people at the right place': Industry
CRO | Features | By BioSpectrum Bureau | 0 Comment | 14 Apr, 2015
The event witnessed more than 35 participants from various top organizations and positions including CEOs, budding startup entrepreneurs, investors, policy makers and directors.In the back ...Read more
-
Lambda Theraputic organizes meet for clinical trial professionals
CRO | News | By BioSpectrum Bureau | 0 Comment | 22 Mar, 2013
Lambda Therapeutic Research successfully conducted a symposium on "Innovation in Clinical Trials" on the 15th and 16th of March, 2013 at Ahmedabad. Around 50 delegates from different pharma...Read more
-
L-Day: Syngene shares soar superb
CRO | News | 0 Comment | 11 Aug, 2015
Shares of Syngene International, a CRO and a subsidiary of biopharmaceutical behemoth Biocon, were listed at Rs 295 today, against its issue price of Rs 250 per share, on the Bombay Stock E...Read more
